Five patients with chronic hepatitis C were treated for one year with the herbal immunomodulatory agent Iscador (Weleda, Schwäbisch Gmünd Germany). Two patients showed 6-20 fold decreases in viral load and normalisation of liver inflammation. The treatment was well tolerated; no serious side effects were observed. The quality of life improved on average. Iscador may have potential as a non toxic therapy for chronic hepatitis C treatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1054/ctim.2000.0408 | DOI Listing |
Publication Analysis
Top Keywords
chronic hepatitis
12
iscador chronic
4
hepatitis exploratory
4
exploratory study
4
study patients
4
patients chronic
4
hepatitis treated
4
treated year
4
year herbal
4
herbal immunomodulatory
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!